CLOV vs NYT · rev $1.37B vs P/E 32, rev $2.59B
Clover Health Investments Corp (CLOV) versus New York Times Company (NYT) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
New York Times Company (NYT) is a publishing company listed on NYSE.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported NYT revenue for 2024-12-31 was $2.59B. Net income was $293.8M. Revenue was up 6.6% from 2023-12-31 to 2024-12-31. NYT currently screens at market cap $12.05B and trailing P/E 32.0.
CLOV currently screens at market cap $1.55B. NYT currently screens at market cap $12.05B and trailing P/E 32.0.
Not investment advice. Open the CLOV and NYT stock pages for the full models.
Not investment advice.